- AudioEye, Inc. (NASDAQ:AEYE) has a ROIC of -14.04% which is significantly lower than its WACC of 6.98%, indicating inefficiency in generating returns to cover its cost of capital.
- ClearPoint Neuro, Inc. faces significant challenges with a ROIC of -40.55% against a WACC of 7.76%, highlighting severe inefficiencies in generating returns on invested capital.
AudioEye, Inc. (NASDAQ:AEYE) is a company that focuses on digital accessibility solutions, helping businesses make their digital content accessible to individuals with disabilities. The company operates in a competitive landscape with peers like Brightcove Inc., ClearPoint Neuro, Inc., Rekor Systems, Inc., DarioHealth Corp., and Apyx Medical Corporation. These companies, while operating in different sectors, share the common challenge of managing their capital efficiently.
In the analysis of AudioEye, the company’s Return on Invested Capital (ROIC) is -14.04%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 6.98%. This negative ROIC indicates that AudioEye is not generating enough returns to cover its cost of capital, which is a critical measure of financial health. The ROIC to WACC ratio of -2.01 further highlights this inefficiency.
Comparatively, ClearPoint Neuro, Inc. presents a more challenging scenario with a ROIC of -40.55% against a WACC of 7.76%, leading to a ROIC to WACC ratio of -5.23. This significant gap suggests that ClearPoint is struggling more than AudioEye in generating returns on its invested capital.
Rekor Systems, Inc. and DarioHealth Corp. also show negative ROICs of -107.12% and -18.93%, respectively, with WACCs of 12.18% and 8.50%. Their ROIC to WACC ratios of -8.79 and -2.23 indicate inefficiencies in capital utilization, similar to AudioEye. Apyx Medical Corporation, with a ROIC of -26.00% and a WACC of 11.51%, has a ROIC to WACC ratio of -2.26, further emphasizing the challenges faced by these companies in generating sufficient returns.
